Delivery Order SPE2DB24D9113-SPE2DB25FEPYF

Award Date 4/1/25
Potential Completion Date 4/22/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,365.06 firm fixed-price delivery order is for the supply of PHOTREXA CROSS-LINKING KIT 6ML medical products and has an ultimate completion date of February 20, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $9,855.93, is a firm fixed-price delivery order for the supply of a PHOTREXA CROSS-LINKING KIT 6ML product. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC...
This federal contract award is for a delivery order valued at $9,855.93, awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of a pharmaceutical product called "PHOTREXA CROSS-LINKING KIT 6ML" to the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price delivery order with no set-aside designation. It is part of a larger indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,855.93 firm fixed-price delivery order is for the supply of a pharmaceutical product, specifically a "PHOTREXA CROSS-LINKING KIT 6ML." The award is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,277.68 Firm Fixed Price delivery order is for the supply of PHOTREXA CROSS-LINKING KIT 6ML, a pharmaceutical product, with a period of performance through October 11, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Firm Fixed Price Delivery Order valued at $19,916.52, with a performance period ending on September 6, 2024. The contract provides for the delivery of "PHOTREXA CROSS-LINKING KIT 6ML" to support the recurring medical supply needs of military health facilities. DMS...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,910.04, is a firm fixed-price delivery order for the PHOTREXA CROSS-LINKING KIT 6ML product. The contract has an ultimate completion date of February 27, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order worth $6,570.64 for the PHOTREXA CROSS-LINKING KIT 6ML product. The contract is a firm fixed-price delivery order with a period of performance through February 12, 2024. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $79,666.08 firm fixed-price Delivery Order contract is for the provision of a medical product, specifically the "PHOTREXA CROSS-LINKING KIT 6ML." This contract award is associated with a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that the DLA has awarded to DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,727.51 firm fixed-price delivery order is for the procurement of the PHOTREXA CROSS-LINKING KIT 6ML medical product. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
  • SPE2DB24D9113
    Indefinite Delivery Contract
  • SPE2DB24D9113-SPE2DB25FEPYF
    Delivery Order

This federal contract award is a $11,182.53 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of "PHOTREXA CROSS-LINKING KIT 6ML" and has an ultimate completion date of April 22, 2025.

DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.

Generated 7/1/25, 9:52 AM